• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Current situation of carboplatin desensitisation protocols in the hospitals of Spain.西班牙医院卡铂脱敏方案的现状。
Eur J Hosp Pharm. 2020 Nov;27(6):369-370. doi: 10.1136/ejhpharm-2018-001746. Epub 2019 Feb 20.
2
Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and monoclonal antibodies following hypersensitivity reactions.化疗药物和单克隆抗体过敏反应后快速脱敏方案的治疗结果。
Intern Med J. 2014 May;44(5):442-9. doi: 10.1111/imj.12320.
3
Carboplatin hypersensitivity reactions: re-treatment with cisplatin desensitisation.卡铂过敏反应:采用顺铂脱敏疗法进行再治疗。
Gynecol Oncol. 2003 Apr;89(1):112-5. doi: 10.1016/s0090-8258(03)00066-0.
4
Carboplatin desensitization.卡铂脱敏疗法。
Ann Allergy Asthma Immunol. 2004 Aug;93(2):137-41. doi: 10.1016/S1081-1206(10)61465-2.
5
Desensitization with oxaliplatin in patients intolerant of carboplatin desensitization.对卡铂脱敏不耐受的患者使用奥沙利铂进行脱敏治疗。
Int J Gynecol Cancer. 2014 Nov;24(9):1603-6. doi: 10.1097/IGC.0000000000000295.
6
Skin Testing in the Evaluation and Management of Carboplatin-Related Hypersensitivity Reactions.皮肤试验在卡铂相关性过敏反应的评估和管理中的应用。
J Allergy Clin Immunol Pract. 2015 Nov-Dec;3(6):856-62. doi: 10.1016/j.jaip.2015.07.003. Epub 2015 Oct 1.
7
A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.一种新的非稀释快速脱敏方案成功应用于所有级别铂类药物过敏。
Cancer Chemother Pharmacol. 2018 Nov;82(5):777-785. doi: 10.1007/s00280-018-3662-0. Epub 2018 Aug 13.
8
Stability of carboplatin infusion solutions used in desensitization protocol.
J Oncol Pharm Pract. 2019 Jul;25(5):1076-1081. doi: 10.1177/1078155218772885. Epub 2018 May 10.
9
Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.门诊快速 4 步脱敏方案用于治疗对卡铂/顺铂有轻度至低中度过敏反应的妇科肿瘤患者。
Gynecol Oncol. 2014 Oct;135(1):90-4. doi: 10.1016/j.ygyno.2014.07.104. Epub 2014 Aug 7.
10
Carboplatin desensitization.卡铂脱敏疗法。
Ann Allergy Asthma Immunol. 2007 Nov;99(5):468-9. doi: 10.1016/S1081-1206(10)60575-3.

引用本文的文献

1
Immune Reactions in Major Types of Oncological Treatment.肿瘤治疗主要类型中的免疫反应。
Int J Mol Sci. 2023 Jul 9;24(14):11257. doi: 10.3390/ijms241411257.

本文引用的文献

1
Stability of carboplatin infusion solutions used in desensitization protocol.
J Oncol Pharm Pract. 2019 Jul;25(5):1076-1081. doi: 10.1177/1078155218772885. Epub 2018 May 10.
2
Outpatient desensitization in selected patients with platinum hypersensitivity reactions.对部分铂类过敏反应患者进行门诊脱敏治疗。
Gynecol Oncol. 2017 Jun;145(3):603-610. doi: 10.1016/j.ygyno.2017.03.015. Epub 2017 Apr 11.
3
A modified protocol for rapid desensitization to chemotherapy agents.一种用于化疗药物快速脱敏的改良方案。
J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):1003-5. doi: 10.1016/j.jaip.2016.05.015. Epub 2016 Jun 24.
4
Platinum hypersensitivity and desensitization.铂超敏反应与脱敏
Jpn J Clin Oncol. 2015 Sep;45(9):795-804. doi: 10.1093/jjco/hyv081. Epub 2015 Jun 7.
5
Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century.21 世纪化疗和单克隆抗体药物过敏反应的快速药物脱敏治疗。
J Investig Allergol Clin Immunol. 2014;24(2):72-9; quiz 2 p following 79.
6
Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity.化疗药物过敏的快速脱敏治疗的结果和安全性。
Expert Opin Drug Saf. 2010 Jan;9(1):39-53. doi: 10.1517/14740330903446936.
7
Rapid desensitization of hypersensitivity reactions to chemotherapy agents.化疗药物超敏反应的快速脱敏
Curr Drug Saf. 2006 Aug;1(3):243-51. doi: 10.2174/157488606777934413.
8
Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.化疗过敏反应:413例快速脱敏的结果与安全性
J Allergy Clin Immunol. 2008 Sep;122(3):574-80. doi: 10.1016/j.jaci.2008.02.044. Epub 2008 May 27.
9
Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients.癌症患者中卡铂过敏反应发生率的评估。
Gynecol Oncol. 2006 Nov;103(2):608-13. doi: 10.1016/j.ygyno.2006.04.002. Epub 2006 Jun 22.
10
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.紫杉醇联合铂类化疗与传统铂类化疗用于复发性卵巢癌女性的疗效比较:ICON4/AGO-OVAR-2.2试验
Lancet. 2003 Jun 21;361(9375):2099-106. doi: 10.1016/s0140-6736(03)13718-x.

西班牙医院卡铂脱敏方案的现状。

Current situation of carboplatin desensitisation protocols in the hospitals of Spain.

机构信息

Pharmacy, Hospital Universitario de Getafe, Getafe, Spain

Pharmacy, Hospital Universitario de Getafe, Getafe, Spain.

出版信息

Eur J Hosp Pharm. 2020 Nov;27(6):369-370. doi: 10.1136/ejhpharm-2018-001746. Epub 2019 Feb 20.

DOI:10.1136/ejhpharm-2018-001746
PMID:33097622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7856132/
Abstract

Desensitisation protocols allow the continuation of treatment in patients who have presented hypersensitivity reactions. Carboplatin desensitisation solutions are usually prepared in the chemotherapy centralised units of hospital pharmacies and they are diluted under the established concentration limit to guarantee the stability of the preparation. An online survey was sent to hospital pharmacies, inquiring about local desensitisation protocols: reasons for use of desensitisation protocols, the protocols used and the stability given to carboplatin solutions. An important variability among the hospitals in carboplatin desensitisation practice was detected. Six different carboplatin desensitisation protocols were described and discordance with the storage period of the carboplatin solutions was observed. The lack of consensus on which protocol must be followed and data supporting the stability of the diluted product, contribute to distrust of carboplatin desensitisation protocols. Although the efficacy and safety of carboplatin desensitisation protocols has been widely demonstrated, many professionals still have concerns.

摘要

脱敏方案允许在出现过敏反应的患者中继续治疗。卡铂脱敏溶液通常在医院药房的化疗集中单元中制备,并在既定浓度限制下稀释,以保证制剂的稳定性。我们向医院药房发送了一份在线调查,询问有关局部脱敏方案的问题:使用脱敏方案的原因、使用的方案以及卡铂溶液的稳定性。我们发现医院之间在卡铂脱敏实践方面存在很大差异。描述了六种不同的卡铂脱敏方案,并观察到卡铂溶液的储存期限不一致。缺乏必须遵循的方案共识以及有关稀释产品稳定性的数据,导致对卡铂脱敏方案的不信任。尽管卡铂脱敏方案的疗效和安全性已得到广泛证明,但许多专业人员仍存在疑虑。